Adtalem Global Education Inc
For the period ended Jun 30, 2024. Filed Aug 6, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Aug 6, 2024
Contents
Restructuring Expense
- Restructuring Expense
During fiscal year 2024, Adtalem recorded restructuring expense primarily driven by prior real estate consolidations at Adtalem’s home office. We continue to incur restructuring charges or reversals related to exited leased space from previous restructuring activities. During fiscal year 2023, Adtalem recorded restructuring expense primarily driven by real estate consolidations at Walden, Medical and Veterinary, and Adtalem’s home office resulting in impairments on operating lease assets and property and equipment. During fiscal year 2022, Adtalem recorded restructuring expense primarily driven by workforce reductions and contract terminations related to synergy actions with regards to the Walden acquisition and Medical and Veterinary and Adtalem’s home office real estate consolidations. When estimating costs of exiting lease space, estimates are made which could differ materially from actual results and may result in additional restructuring charges or reversals in future periods. Termination benefit charges represent severance pay and benefits for employees impacted by workforce reductions. Adtalem’s home office is classified as “Home Office” in Note 22 “Segment Information.”Restructuring expense by segment were as follows (in thousands):
| · · · · · · · · · | ||||||||
|---|---|---|---|---|---|---|---|---|
| · · Year Ended June 30, 2024 | ||||||||
| · · Real Estateand Other · · TerminationBenefits · · Total | ||||||||
| Walden | | $(776) | $— | $(776) | ||||
| Medical and Veterinary | | | 402 | | 40 | | 442 | |
| Home Office | | | 2,204 | | — | | 2,204 | |
| Total | | $1,830 | | $40 | | $1,870 | ||
| · · · · · · · · · | ||||||||
|---|---|---|---|---|---|---|---|---|
| · · Year Ended June 30, 2023 | ||||||||
| · · Real Estateand Other · · TerminationBenefits · · Total | ||||||||
| Chamberlain | | $818 | $— | $818 | ||||
| Walden | | | 3,191 | | 54 | | 3,245 | |
| Medical and Veterinary | | | 7,071 | | 616 | | 7,687 | |
| Home Office | | | 6,117 | | 950 | | 7,067 | |
| Total | | $17,197 | | $1,620 | | $18,817 | ||
| · · · · · · · · · | ||||||||
|---|---|---|---|---|---|---|---|---|
| · · Year Ended June 30, 2022 | ||||||||
| · · Real Estateand Other · · TerminationBenefits · · Total | ||||||||
| Chamberlain | | $835 | $2,003 | $2,838 | ||||
| Walden | | | — | | 4,053 | | 4,053 | |
| Medical and Veterinary | | | 7,675 | | 2,116 | | 9,791 | |
| Home Office | | | 5,977 | | 2,969 | | 8,946 | |
| Total | | $14,487 | | $11,141 | | $25,628 | ||
The following table summarizes the separation and restructuring plan activity for fiscal years 2023 and 2024, for which cash payments are required (in thousands):
| · · · | ||
|---|---|---|
| Liability balance as of June 30, 2022 | | $813 |
| Increase in liability (separation and other charges) | | 1,620 |
| Reduction in liability (payments and adjustments) | | (1,692) |
| Liability balance as of June 30, 2023 | | 741 |
| Increase in liability (separation and other charges) | | 40 |
| Reduction in liability (payments and adjustments) | | (781) |
| Liability balance as of June 30, 2024 | | $— |
These liability balances are recorded as accrued liabilities on the Consolidated Balance Sheets.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.